about
sameAs
Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.Cardiovascular prophylaxis with aspirin: costs of supply and management of upper gastrointestinal and renal toxicityDabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analysesAmerican, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectively.
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Costs of aspirin and statins in general practice
@ast
Costs of aspirin and statins in general practice
@en
Costs of aspirin and statins in general practice
@nl
type
label
Costs of aspirin and statins in general practice
@ast
Costs of aspirin and statins in general practice
@en
Costs of aspirin and statins in general practice
@nl
prefLabel
Costs of aspirin and statins in general practice
@ast
Costs of aspirin and statins in general practice
@en
Costs of aspirin and statins in general practice
@nl
P2093
P356
P1476
Costs of aspirin and statins in general practice
@en
P2093
P356
10.1093/QJMED/95.1.23
P407
P577
2002-01-01T00:00:00Z